Respiratory syncytial virus clinical trial

Respiratory syncytial virus, or RSV, is a common respiratory (lungs and aiways) virus that usually causes mild, cold-like symptoms. Often people recover in a week or two, but RSV can be deadly, especially for infants and older adults.

Currently, there is no specific treatment or approved vaccine to protect our infant population against RSV. Mater is running a RSV vaccine study in pregnant women at
Mater Mother’s Hospital and we need your help.

If you are between 18–49 years of age and are 24–34 weeks pregnant and are interested in being part of this important study, please contact our team for more information. 


Mater RSV team email: